Clinical Trial: A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases
Study Status: Completed
Recruit Status: RECRUITING
Condition: Allergic Disease
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo/Active Controlled, Single Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of
Brief Summary:
This study aims to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) following a single subcutaneous injection of YH35324 in subjects with various allergic diseases.
Read more